IP Library Assignment 075969/0966
Patent Assignment
Reel/Frame 075969/0966

Security Interest

Recorded: 2026-07-14 Pages: 13
Assignors
CYDEX PHARMACEUTICALS, INC.
Executed: 2026-07-14
METABASIS THERAPEUTICS, INC.
Executed: 2026-07-14
XOMA (US) LLC
Executed: 2026-07-14
APEIRON BIOLOGICS GMBH
Executed: 2026-07-14
Assignee
CITIBANK, N.A., AS ADMINISTRATIVE AGENT
6400 LAS COLINAS BLVD., MAIL STOP CC1-30, IRVING, TEXAS, 75039
Covered Properties (58)
Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
Application: 18/244,141 →
Publication: US US20240156766A1
Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
Application: 18/363,940 →
Publication: US US20240139137A1
Cyclic Phosphoramidate Compounds
Application: 18/706,719 →
Publication: US US20250188111A1
Nitric Oxide-Releasing Nasal Compositions and Methods of Use Thereof
Application: 18/719,012 →
Publication: US US20250049841A1
Unnatural Configuration Nucleotide Prodrug Compounds
Application: 18/561,681 →
Publication: US US20240294565A1
Preparations and Methods for Treating a GD2 Positive Cancer
Application: 19/404,977 →
Publication: US US20260092126A1
Preparations and Methods for Treating a GD2 Positive Cancer
Application: 19/429,318 →
Publication: US US20260132216A1
Preparations and Methods for Treating a GD2 Positive Cancer
Application: 18/178,778 →
Publication: US US20240158530A1
Methods for Treatment of Virus
Application: 17/907,182 →
Publication: US US20240093173A1
Method of Treating an Il-1 Related Cancer
Patent: 7,829,094 →
Application: 12/464,061 →
Publication: US US20090214545A1
Formulations for Anti-Insulin Receptor Antibody and Uses Thereof
Application: 18/867,485 →
Publication: US US20260070996A1
Modulators
Application: 19/238,966 →
Publication: US US20260070972A1
Parathyroid Hormone Receptor 1(PTH1R) Antibodies and Uses Thereof
Application: 18/463,087 →
Publication: US US20240158535A1
Alpha-Amino Esters of Hydroxypropylthiazolidine Carboxamide Derivative and Salt Form, Crystal Polymorph Thereof
Application: 16/066,921 →
Publication: US US20190000812A1
Compositions and Methods for the Treatment or Prevention of Preterm Labor
Application: 18/037,007 →
Publication: US US20240024294A1
Anti-CD38 Binding Domains
Application: 16/751,107 →
Publication: US US20200231696A1
Compositions Containing Silymarin and Sulfoalkyl Ether Cyclodextrin and Methods of Using the Same
Application: 17/853,761 →
Publication: US US20230233638A1
Tunable Nitric Oxide-Releasing Macromolecules Having Multiple Nitric Oxide Donor Structures
Application: 17/465,929 →
Publication: US US20210395191A1
Topical Antiviral Compositions, Delivery Systems, and Methods of Using the Same
Application: 18/340,177 →
Publication: US US20230330008A1
Use of Thyroid Beta-Agonists
Application: 18/595,919 →
Publication: US US20250000880A1
Compounds Useful as Raf Kinase Inhibitors
Patent: 8,293,752 →
Application: 12/164,762 →
Publication: US US20090036419A1
Compounds Useful as Raf Kinase Inhibitors
Patent: 8,802,657 →
Application: 13/657,506 →
Publication: US US20130065858A1
Substituted 1,3-Thiazoles as Synthetic Intermediates for Preparation of Raf Kinase Inhibitors
Patent: 9,556,177 →
Application: 14/444,007 →
Publication: US US20150080568A1
Substituted Pyrimidines for Inhibiting Raf Kinase Activity
Patent: 9,920,048 →
Application: 15/380,515 →
Publication: US US20170158686A1
Antibodies That Bind Interleukin-2 and Uses Thereof
Application: 15/718,152 →
Publication: US US20180094053A1
Pharmaceutical Compositions Comprising Il-1B Binding Antibodies and Fragments Thereof
Patent: 9,206,252 →
Application: 13/739,707 →
Publication: US US20140004125A1
Methods for the Treatment of Il-1BETA Related Diseases
Patent: 9,163,082 →
Application: 14/042,205 →
Publication: US US20140255391A1
Il-1BETA Binding Antibodies and Fragments Thereof
Patent: 7,531,166 →
Application: 11/472,813 →
Publication: US US20080044414A1
Nucleic acids encoding IL-1beta binding antibodies
Patent: 7,582,742 →
Application: 12/218,914 →
Publication: US US20090060918A1
Method of Treating an Il-1 Related Inflammatory Disease or Condition
Patent: 7,695,717 →
Application: 12/218,997 →
Publication: US US20090060923A1
IL1-Beta Binding Antibodies and Fragments Thereof
Patent: 7,744,865 →
Application: 12/463,741 →
Publication: US US20090226461A1
Il-1BETA Binding Antibodies and Binding Fragments Thereof
Patent: 7,744,866 →
Application: 12/463,844 →
Publication: US US20090246210A1
Method of Treating an Il-1 Related Autoimmune Disease or Condition
Patent: 7,829,093 →
Application: 12/464,006 →
Publication: US US20090214568A1
Method of Treating an Il-1 Related Coronary Condition
Patent: 7,988,968 →
Application: 12/464,323 →
Publication: US US20100055110A1
Il-1BETA Binding Antibodies and Fragments Thereof
Patent: 7,943,121 →
Application: 12/464,381 →
Publication: US US20100061998A1
A Method of Treating Inflammatory Eye Disease with Il-1BETA Binding Antibodies
Patent: 8,377,442 →
Application: 13/109,680 →
Publication: US US20120014967A1
Methods for the Treatment of Il-1BETA Related Diseases
Patent: 7,695,718 →
Application: 11/961,764 →
Publication: US US20080292640A1
Methods for the Treatment of Il-1BETA Related Diseases
Patent: 8,101,166 →
Application: 12/710,842 →
Publication: US US20100303807A1
Methods for Improvement of Beta Cell Function with Anti-Il-1BETA Antibodies or Fragments Thereof
Patent: 8,377,429 →
Application: 13/062,461 →
Publication: US US20120005127A1
Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat Hypoglycemia
Application: 15/230,340 →
Publication: US US20170037135A1
Novel Modulators
Application: 17/575,577 →
Publication: US US20220227857A1
Novel Modulators
Patent: 8,926,976 →
Application: 12/890,598 →
Publication: US US20110076284A1
Novel Modulators
Patent: 9,725,510 →
Application: 14/555,243 →
Publication: US US20150322157A1
Novel Modulators
Patent: 9,944,698 →
Application: 14/555,233 →
Publication: US US20160009800A1
Antibodies That Bind Interleukin-2 and Uses Thereof
Application: 17/112,664 →
Publication: US US20210188969A1
Parathyroid Hormone Receptor 1 (PTH1R) Antibodies and Uses Thereof
Application: 15/665,788 →
Publication: US US20180030154A1
Treatment of Post-Prandial Hyperinsulinemia and Hypoglycemia After Bariatric Surgery
Application: 15/555,608 →
Publication: US US20180037658A1
Parathyroid Hormone Receptor 1 (PTH1R) Antibodies and Uses Thereof
Application: 16/696,068 →
Publication: US US20200317817A1
Alpha-Amino Esters of Hydroxypropylthiazolidine Carboxamide Derivative and Salt Form, Crystal Polymorph Thereof
Application: 16/752,961 →
Publication: US US20200155515A1
Compositions and Methods for Delaying the Incidence of Labor
Application: 16/411,974 →
Methods for the Treatment of Uveitis with Il-1B Binding Antibodies
Patent: 9,139,646 →
Application: 14/029,603 →
Publication: US US20140242090A1
Novel Modulators
Application: 15/921,176 →
Publication: US US20180371081A1
Flexible Manufacturing System
Application: 15/349,298 →
Publication: US US20170058508A1
Novel Triple Tag Sequence and Methods of Use Thereof
Patent: 8,546,307 →
Application: 12/572,877 →
Publication: US US20100184612A1
Novel Triple Tag Sequences and Methods of Use Thereof
Patent: 8,546,308 →
Application: 13/244,871 →
Publication: US US20120010101A1
Cardiovascular Related Uses of Il-1BETA Antibodies and Binding Fragments Thereof
Application: 15/647,203 →
Publication: US US20180155420A1
Flexible Manufacturing System
Application: 13/129,073 →
Publication: US US20110258837A1
Anti-CD38 Binding Domains
Application: 17/810,377 →
Publication: US US20230203186A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 16, 2008
From: CHEN, WEIRONG; FRANKLIN, LLOYD; GUAN, BING; JONES, JOHN HOWARD
To: BIOGEN IDEC MA INC.
Reel/Frame 021707/0639 →
Assignment of Assignor's Interest Oct 16, 2008
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 021688/0887 →
Assignment of Assignor's Interest Jul 7, 2009
From: MASAT, LINDA; HAAK-FRENDSCHO, MARY; HORWITZ, ARNOLD; CHEN, GANG
To: XOMA TECHNOLOGY LTD.
Reel/Frame 022920/0778 →
Confirmation of Assignment-Joint Ownership Between Biogen Idec Ma Inc. and Sunesis Pharmaceutcials, Inc. Jul 17, 2009
From: SUNESIS PHARMACEUTICALS, INC.; BIOGEN IDEC MA INC.
To: SUNESIS PHARMACEUTICALS, INC.; BIOGEN IDEC MA INC.
Reel/Frame 022974/0444 →
Confirmation of Assignment-Joint Ownership Between Biogen Idec Ma Inc. and Sunesis Pharmaceuticals, Inc. Jul 17, 2009
From: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
To: SUNESIS PHARMACEUTICALS, INC.; BIOGEN IDEC MA INC.
Reel/Frame 022974/0461 →
Assignment of Assignor's Interest Dec 23, 2011
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 027441/0954 →
Corrective Assignment to Correct the Assignment Document Previously Recorded on Reel 022920 Frame 0778. Assignor(S) Hereby Confirms the Assignment. Apr 11, 2012
From: MASAT, LINDA; HAAK-FRENDSCHO, MARY; HORWITZ, ARNOLD; ROELL, MARINA
To: XOMA TECHNOLOGY LTD.
Reel/Frame 028030/0845 →
Assignment of Assignor's Interest Apr 11, 2012
From: CHEN, GANG
To: DIVERSA CORPORATION
Reel/Frame 028029/0941 →
Assignment of Assignor's Interest Apr 11, 2012
From: DIVERSA CORPORATION
To: XOMA TECHNOLOGY LTD.
Reel/Frame 028029/0951 →
Assignment of Assignor's Interest Jan 22, 2014
From: XOMA TECHNOLOGY LTD.
To: XOMA (US) LLC
Reel/Frame 032023/0011 →
Security Interest May 9, 2018
From: XOMA (US) LLC
To: SILICON VALLEY BANK
Reel/Frame 046115/0408 →
Assignment of Assignor's Interest Jul 9, 2018
From: LOUMAYE, ERNEST; POHL, OLIVER; GOTTELAND, JEAN-PIERRE
To: OBSEVA S.A.
Reel/Frame 046297/0015 →
Assignment of Assignor's Interest Jul 9, 2018
From: PAGE, PATRICK; JORAND-LEBRUN, CATHERINE; QUATTROPANI, ANNA
To: MERCK SERONO S.A.
Reel/Frame 046296/0859 →
Assignment of Assignor's Interest Jul 9, 2018
From: SCHWARZ, MATTHIAS
To: MERCK SERONO S.A.
Reel/Frame 046296/0706 →
Assignment of Assignor's Interest Jul 9, 2018
From: MERCK SERONO S.A.
To: OBSEVA S.A.
Reel/Frame 046297/0091 →
Assignment of Assignor's Interest Jul 9, 2018
From: POMEL, VINCENT
To: MERCK SERONO S.A.
Reel/Frame 046296/0640 →
Security Interest Aug 7, 2019
From: OBSEVA SA
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049994/0930 →
Assignment of Assignor's Interest Feb 14, 2020
From: ELIAS, KATHLEEN ANN; LANDES, GREGORY; SINGH, SHWETA; KORVER, WOUTER
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 051825/0798 →
Assignment of Assignor's Interest Apr 1, 2020
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 052288/0694 →
Assignment of Assignor's Interest Jun 30, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056729/0503 →
Merger May 17, 2022
From: DOT THERAPEUTICS-2, INC.; DOT THERAPEUTICS-1, INC.
To: DAY ONE BIOPHARMACEUTICALS, INC.
Reel/Frame 059936/0096 →
Assignment of Assignor's Interest Jun 22, 2022
From: WILLERT, ERIN
To: MOLECULAR TEMPLATES, INC.; MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 060274/0237 →
Assignment of Assignor's Interest Jun 22, 2022
From: BHASKAR, VINAY; ELIAS, KATHLEEN ANN; LANDES, GREGORY; SINGH, SHWETA
To: XOMA (US) LLC.; TAKEDA DEVELOPMENT CENTER AMERICAS, INC.; MILLENNIUM PHARMACEUTICALS, INC.; TAKEDA PHARMACEUTICALS COMPANY LIMITED
Reel/Frame 060274/0136 →
Assignment of Assignor's Interest Jun 22, 2022
From: MILLENNIUM PHARMACEUTICALS, INC.
To: TAKEDA PHARMACEUTICALS COMPANY LIMITED
Reel/Frame 060402/0282 →
Release of Security Interest Jul 6, 2022
From: OXFORD FINANCE LLC
To: OBSEVA S.A.
Reel/Frame 060410/0839 →